Multiple myeloma in the elderly patients:From frailty assessment to progress in Immunotherapy

被引：1
作者：
Facon, T. [1 ]
Manier, S. [1 ]
机构：
[1] CHU Lille, Hop Claude Huriez, Serv dhematol, 2 Ave Oscar Lambret, F-59037 Lille, France
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2022年 / 206卷 / 08期
关键词：
Multiple myeloma; Drug Therapy; Therapy; Immunotherapy; Oncogeriatry; Frail elderly patient; STEM-CELL TRANSPLANTATION; OPEN-LABEL; GERIATRIC ASSESSMENT; DEXAMETHASONE; BORTEZOMIB; MELPHALAN; LENALIDOMIDE; PREDNISONE; PHASE-3; DARATUMUMAB;
D O I：
10.1016/j.banm.2022.07.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multiple myeloma is primarily a disease of the elderly patients. Geriatric aspects have been poorly investigated until recently. Frailty assessment is now more frequent and will be useful in the context of significant and sustained therapeutic progress. The recent emergence of immunotherapy with CD38 monoclonal antibodies and upcoming immuno-oncology drugs such as bispecific antibodies will lead to additional progress. The applicability of these complex molecules to elderly and frail patients is a key clinical question.(c) 2022 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：966 / 972
页数：7
相关论文
共 50 条
  • [31] How First-Line Therapy is Changing in non-Transplant Eligible Multiple Myeloma Patients
    Fazio, Francesca
    Deiana, Luca
    Loi, Cristian
    Mura, Francesca
    Petrucci, Maria Teresa
    Derudas, Daniele
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [32] Research progress on treatment of extramedullary multiple myeloma
    Chen, Yue
    Tao, Shandong
    Zheng, Xinqi
    Shi, Yuye
    Zhang, Lijuan
    Chen, Kankan
    He, Zhengmei
    Wang, Chunling
    Yu, Liang
    HEMATOLOGY, 2021, 26 (01) : 985 - 994
  • [33] Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
    Palumbo, Antonio
    Bringhen, Sara
    Mateos, Maria-Victoria
    Larocca, Alessandra
    Facon, Thierry
    Kumar, Shaji K.
    Offidani, Massimo
    McCarthy, Philip
    Evangelista, Andrea
    Lonial, Sagar
    Zweegman, Sonja
    Musto, Pellegrino
    Terpos, Evangelos
    Belch, Andrew
    Hajek, Roman
    Ludwig, Heinz
    Stewart, A. Keith
    Moreau, Philippe
    Anderson, Kenneth
    Einsele, Hermann
    Durie, Brian G. M.
    Dimopoulos, Meletios A.
    Landgren, Ola
    San Miguel, Jesus F.
    Richardson, Paul
    Sonneveld, Pieter
    Rajkumar, S. Vincent
    BLOOD, 2015, 125 (13) : 2068 - 2074
  • [34] The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
    Shimazu, Yutaka
    Kanda, Junya
    Suzuki, Kazuhito
    Wada, Akinori
    Kikuchi, Taku
    Ikeda, Takashi
    Tsukada, Nobuhiro
    Miwa, Akiyoshi
    Itagaki, Mitsuhiro
    Kako, Shinichi
    Nishiwaki, Kaichi
    Ota, Shuichi
    Fujiwara, Shin-ichiro
    Kataoka, Keisuke
    Doki, Noriko
    Sawa, Masashi
    Hiramoto, Nobuhiro
    Nishikawa, Akinori
    Imai, Toshi
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Kawamura, Koji
    CANCER SCIENCE, 2024, 115 (07) : 2384 - 2395
  • [35] Multiple Myeloma in 2023 Ways: From Trials to Real Life
    Fazio, Manlio
    Del Fabro, Vittorio
    Parrinello, Nunziatina Laura
    Allegra, Alessandro
    Markovic, Uros
    Botta, Cirino
    Accardi, Fabrizio
    Vincelli, Iolanda Donatella
    Leotta, Salvatore
    Elia, Federica
    Esposito, Benedetta
    Garibaldi, Bruno
    Sapuppo, Gabriele
    Orofino, Alessandra
    Romano, Alessandra
    Palumbo, Giuseppe A.
    Di Raimondo, Francesco
    Conticello, Concetta
    CURRENT ONCOLOGY, 2023, 30 (11) : 9710 - 9733
  • [36] Treatment of multiple myeloma in the elderly: realities and hopes
    De La Rubia, Javier
    Sanz, Miguel A.
    LEUKEMIA & LYMPHOMA, 2011, 52 (01) : 9 - 14
  • [37] Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
    Azarm, Taleb
    Akbari, Mojtaba
    Azarm, Arezo
    Mohager, Hamid
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (01): : 8 - 14
  • [38] Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies
    Caroni, Federico
    Sammartano, Vincenzo
    Pacelli, Paola
    Sicuranza, Anna
    Malchiodi, Margherita
    Dragomir, Andreea
    Ciofini, Sara
    Raspadori, Donatella
    Bocchia, Monica
    Gozzetti, Alessandro
    PHARMACEUTICALS, 2025, 18 (02)
  • [39] Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis
    Suzuki, Kazuhito
    Mizuno, Shohei
    Shimazu, Yutaka
    Fuchida, Shin-ichi
    Hagiwara, Shotaro
    Itagaki, Mitsuhiro
    Nishiwaki, Kaichi
    Hangaishi, Akira
    Karasuno, Takahiro
    Kikuchi, Taku
    Shimizu, Misayo
    Nishikawa, Akinori
    Kobayashi, Takeshi
    Sunami, Kazutaka
    Hiramoto, Nobuhiro
    Uchiyama, Hitoji
    Maruyama, Yumiko
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    Kawamura, Koji
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (04) : 444 - 454
  • [40] Recent Advances in the Treatment of Patients with Multiple Myeloma
    Legarda, Mario A.
    Cejalvo, Maria J.
    de la Rubia, Javier
    CANCERS, 2020, 12 (12) : 1 - 22
12345